SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Fujiki, F. Aucejo, R. Kim, Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: do we really need this?, Clinical Transplantation, 2013, 27, 2
  2. 2
    Young Chul Yoon, Tae Ho Hong, Young Kyoung You, Dong Goo Kim, Clinical analysis of recurrent hepatocellular carcinoma after living donor liver transplantation, Clinical Transplantation, 2013, 27, 2
  3. 3
    Jun Yan, Changjun Tan, Fangming Gu, Jiahao Jiang, Min Xu, Xiuzhen Huang, Zhi Dai, Zheng Wang, Jia Fan, Jian Zhou, Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase, Liver Transplantation, 2013, 19, 5
  4. 4
    Shirin Elizabeth Khorsandi, Nigel Heaton, Contemporary Strategies in the Management of Hepatocellular Carcinoma, HPB Surgery, 2012, 2012, 1

    CrossRef

  5. 5
    Emmanuel Melloul, Mickael Lesurtel, Brian I. Carr, Pierre-Alain Clavien, Developments in Liver Transplantation for Hepatocellular Carcinoma, Seminars in Oncology, 2012, 39, 4, 510

    CrossRef

  6. 6
    Qi-Da Hu, Wei Chen, Tian-Lian Yan, Tao Ma, Cong-Lin Chen, Chao Liang, Qi Zhang, Xue-Feng Xia, Hao Liu, Xiao Zhi, Xiao-Xiao Zheng, Xue-Li Bai, Xia-Zhen Yu, Ting-Bo Liang, NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial–mesenchymal transition in hepatocellular carcinoma cells, Cancer Letters, 2012, 325, 2, 207

    CrossRef

  7. 7
    Pierre-Alain Clavien, Mickael Lesurtel, Patrick MM Bossuyt, Gregory J Gores, Bernard Langer, Arnaud Perrier, Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report, The Lancet Oncology, 2012, 13, 1, e11

    CrossRef

  8. 8
    J. R. L. Maggs, A. R. Suddle, V. Aluvihare, M. A. Heneghan, Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma, Alimentary Pharmacology & Therapeutics, 2012, 35, 10
  9. 9
    Ali Zarrinpar, Fady Kaldas, Ronald W Busuttil, Liver transplantation for hepatocellular carcinoma: an update, Hepatobiliary & Pancreatic Diseases International, 2011, 10, 3, 234

    CrossRef

  10. 10
    C. Toso, G. Mentha, P. Majno, Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence, American Journal of Transplantation, 2011, 11, 10
  11. 11
    J.-Y. Mabrut, C. Ducerf, Prise en charge chirurgicale du carcinome hépatocellulaire en 2010, Cancer/Radiothérapie, 2011, 15, 1, 13

    CrossRef

  12. 12
    Christophe Duvoux, Tetsuya Kiuchi, Bernhard Pestalozzi, Ronald Busuttil, Rebecca Miksad, What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?, Liver Transplantation, 2011, 17, S2
  13. 13
    Chuanxing Li, Fujun Zhang, Weidong Zhang, Liang Zhang, Zilin Huang, Peihong Wu, Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, 2010, 136, 11, 1633

    CrossRef

  14. 14
    Ozgur Firat, Ozgur Kirdok, Ozer Makay, Cemil Caliskan, Funda Yilmaz, Savas Ilgezdi, Bulent Karabulut, Ahmet Coker, Murat Zeytunlu, Can hyperbaric oxygenation decrease doxorubicin hepatotoxicity and improve regeneration in the injured liver?, Journal of Hepato-Biliary-Pancreatic Surgery, 2009, 16, 3
  15. 15
    A. Hollebecque, T. Decaens, E. Boleslawski, P. Mathurin, C. Duvoux, F.-R. Pruvot, S. Dharancy, Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation, Gastroentérologie Clinique et Biologique, 2009, 33, 5, 361

    CrossRef

  16. 16
    T. Decaens, M. Hurtova, C. Duvoux, Transplantation hépatique pour carcinome hépatocellulaire, Gastroentérologie Clinique et Biologique, 2009, 33, 1, 61

    CrossRef

  17. 17
    Jing Xu, Zhong-Yang Shen, Xin-Guo Chen, Qing Zhang, Hui-Jie Bian, Ping Zhu, Hui-Yun Xu, Fei Song, Xiang-Min Yang, Li Mi, Qing-Chuan Zhao, Rong Tian, Qiang Feng, Si-He Zhang, Yu Li, Jian-Li Jiang, Ling Li, Xiao-Ling Yu, Zheng Zhang, Zhi-Nan Chen, A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation, Hepatology, 2007, 45, 2
  18. 18
    J. Lerut, Carcinome hépatocellulaire et transplantation hépatique : état des lieux, Journal de Chirurgie, 2007, 144, 2, 105

    CrossRef

  19. 19
    Shimul A. Shah, Jensen C. C. Tan, Ian D. McGilvray, Mark S. Cattral, Gary A. Levy, Paul D. Greig, David R. Grant, Does Microvascular Invasion Affect Outcomes After Liver Transplantation for HCC? A Histopathological Analysis of 155 Consecutive Explants, Journal of Gastrointestinal Surgery, 2007, 11, 4, 464

    CrossRef

  20. 20
    Katharina Schmid, Xiaowei Wang, Andrea Haitel, Wolfgang Sieghart, Markus Peck-Radosavljevic, Martin Bodingbauer, Susanne Rasoul-Rockenschaub, Fritz Wrba, KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study, Virchows Archiv, 2007, 450, 2, 143

    CrossRef

  21. 21
    Gunnar Söderdahl, Lars Bäckman, Helena Isoniemi, Christian Cahlin, Krister Höckerstedt, Ulrika Broomé, Heikki Mäkisalo, Styrbjörn Friman, Bo-Göran Ericzon, A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma, Transplant International, 2006, 19, 4
  22. 22
    Jordi Bruix, Morris Sherman, Management of hepatocellular carcinoma, Hepatology, 2005, 42, 5
  23. 23
    John P. Roberts, Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation, Liver Transplantation, 2005, 11, S2